SEC Form 4 · accession 0001437749-17-005651
CESCA THERAPEUTICS INC. · KOOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly Kay Ellner
Officer — VP, Manufacturing
Period of report
Mar 27, 2017
Accepted (ET)
Mar 30, 2017 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2017 | A | 162 | $3.15 | D | 4,037 | D | |
| Common Stock | Mar 28, 2017 | A | 2,338 | $3.15 | D | 1,699 | D |
Table II — derivative securities
No Table II lines on this filing.